Adenocarcinoma of the stomach: Univariate and multivariate analysis of factors associated with survival

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 1, 2002, Pages 84-89

  Green, Dan ^a   De Leon, Sergio Ponce ^a   Leon Rodriguez, Eucario ^a   Sosa Sanchez, Ricardo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Chemotherapy; Gastric cancer; Multivariate analysis; Prognostic factors; Survival; Univariate analysis

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036161936     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200202000-00018     Document Type: Article

References (53)

1. Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition
2. Gastric adenocarcinoma: Management of the primary disease
3. Gastrointestinal cancer
4. Estimation of validity of mass screening program for gastric cancer in Osaka, Japan
5. Increased incidence of undifferentiated type of gastric Cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer
6. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer
7. Adjuvant therapy of upper gastrointestinal tract cancers
8. Principles of radical surgery in gastric carcinoma
9. Clinical implications of recent developments in gastric cancer pathology and epidemiology
10. Prognostic factors in gastric carcinoma
11. Carcinoma of the esophagogastric junction
12. Cancer of the distal esophagus and cardia
13. Gastrointestinal cancer
14. Surgical considerations in gastric cancer
15. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer
16. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients
17. Adenocarcinoma gastrico: Analisis de 177 casos vistos en el INNSZ en los ultimos 5 años
18. Total Gastrectomy for advanced cancer
19. Gastric cancer: Contemporary aspects
20. Has there been any improvement in the staging of gastric cancer? Findings from the Germany Gastric Cancer TNM Study Group
21. A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach
22. Advanced gastric cancer: A new combined surgical and oncological approach
23. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
24. Phase II study with the combination of etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer
25. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer
26. Toxicity and response criteria of the Eastern Cooperative Oncology Group
27. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathological and treatment factors
28. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the general rules for gastric cancer study by the Japanese Research Society for Gastric Cancer
29. Adenocarcinoma of the stomach: Changing patterns over the last 4 decades
30. Cancer of the stomach
31. Radical surgery for gastric cancer: A review of the Japanese experience
32. Reporting results of cancer treatment
33. Nonparametric estimation from incomplete observations
34. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
35. Regression models and life-tables
36. The National Cancer Data Base Report on gastric cancer
37. Nativity, complications, and pathology are determinants of surgical results for gastric cancer
38. New developments in the treatment of gastric carcinoma
39. Helicobacter pylori infection and the risk of gastric carcinoma
40. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
41. Helicobacter pylori: A common worldwide environmental risk factor for gastric cancer
42. Possible role of Helicobacter pylori infection in early gastric cancer development
43. Flow cytometry as a predictive indicator in patients with operable gastric cancer
44. A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery
45. Influence of the extent of resection on survival after curative treatment of gastric carcinoma
46. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer
47. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: Results of a phase II trial
48. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer. An old lesson revisited
49. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trial